Company: MYSZ
Filing Date: 2025-11-14
Form Type: 10-Q
Source: 0001493152-25-023456
Chunk: 29

Company: My Size, Inc.
Filing Date: 2025-11-14
Form: 10-Q
Item: Part I, Item 8
Chunk 29
---
319  
     3,313,569  
     1,040,446 

Nine
and Three Months Ended September 30, 2025 Compared to Nine and Three Months Ended September 30, 2024

Revenues

Our
revenues for the nine months ended September 30, 2025 amounted to $6,057,000 compared to $6,802,000 for the nine months ended September
30, 2024. The decrease in the nine months ended September 30, 2025 from the corresponding period is primarily attributable to a decrease
in Orgad sales.

Our
revenues for the three months ended September 30, 2025 amounted to $2,572,000 compared to $1,839,000 for the three months ended September
30, 2024. The increase in the three months ended September 30, 2024 from the corresponding period is primarily attributable to the inclusion
of New Percentil in the consolidated reporting as of September 30, 2025.

Cost
of Revenues

Our
cost of revenues for the nine months ended September 30, 2025 amounted to $3,504,000 compared to $3,831,000 for the nine months ended
September 30, 2024. The decrease in comparison with the corresponding period was mainly due to transition to fulfillment by Amazon shipping
and warehousing method.

Our
cost of revenues expenses for the three months ended September 30, 2025 amounted to $1,563,000 compared to $1,048,000 for the three months
ended September 30, 2024. The increase in comparison with the corresponding period was attributable to the inclusion of New Percentil
and ShoeSizeMe in the consolidated reporting as of September 30, 2025.

Research
and Development Expenses

Our
research and development expenses for the nine months ended September 30, 2025 amounted to $355,000 compared to $352,000 for the nine
months ended September 30, 2024. The increase from the corresponding period was mainly due to the annual salary increase of the retained
employees in Naiz Fit and inclusion of New Percentil in the consolidated reporting as of September 30, 2025.

Our
research and development expenses for the three months ended September 30, 2025 amounted to $131,000 compared to $89,000 for the three
months ended September 30, 2024